HHG GROUP
Language
Direction Contact us
Mitera MENU
Faliakou Eleni

Faliakou Eleni Breast Surgeon

Director, 2nd Breast Clinic

Education & Academic Qualifications

  • 1981-1987
    Medical Degree University of Athens Medical School, Greece
  • 1988-1991 Internship and Residency in General Surgery,
    First Dept of Surgery, University of Athens Medical School, Laiko Hospital Athens, Greece
  • 1991-1992 Research Fellow, Surgical Research Lab,
    Department of Surgery, New England Medical Center, Tufts University, Boston, MA, USA
  • 1992-1994 Intership and Residency in General Surgery
    Department of Surgery, MCV, Medical College of Virginia, University of Virginia Commonwealth, Richmond, VA, USA
  • 1994-1997 Residency in General Surgery,
    Department of Surgery UAMS-University of Arkansas for Medical Sciences, Little Rock, AR, USA
  • 1998-2000 Clinical Fellow in Breast Surgery
    Academic Surgery- Breast Surgery Unit
    Royal Marsden Hospital, London Fulham Road, UK

Licensure And Certification

  • 1987 Greek Medical License-Prefecture of Athens
  • 1995 State of Arkansas Medical License
  • 1991 E.C.F.M.G
  • 1993 FLEX State Board of Medicine Commonwealth of Pennsylvania
  • 1998 Certificate of Completion of Specialist Training in General Surgery, Athens, Greece
  • 1998 Certificate of full registration in the Principal List of the register of medical practitioners in London, UK
  • 1998 CCST -General Surgery
  • Included in the Specialist Register under the European Specialist Medical Qualification

Previous Clinical Appointments

  • 2000-2010 Attending Breast Surgeon, Breast Unit, Leto Maternity Hospital , Athens, Greece
  • 2000-2005 Attending Breast Surgeon, Prolipsis Breast Center, Athens, Greece
  • 2010-2015 Clinical Director, Breast Center and Breast Clinic Euroclinic of Athens, Athens, Greece

Current Clinical Appointment

Head, 2nd Breast Unit, Mitera Hospital, Athens, Greece

Professional Societies

  • 1992-1999 American Medical Association
  • 1996-1998 American College of Surgeons
    (Candidate Group)
  • 1999-2005 ESSO-Affiliate member
    European School of Oncology (ECO)
  • 2001  Greek Senologic Society
  • 1987-present Greek Medical Association
    present  BASO-British Association of Surgical Oncology
    ABS Association of Breast Surgery
  • 1999- present  EUSOMA 
    European Society of Breast Cancer Specialist
  • 1999-present Greek Surgical Association
  • 2001-present Hellenic Breast Surgical Society
  • 2002-present American Society of Breast Diseases 
  • 2010  Member of the Scientific Committee of “
    Alma Zois” a non profit organization
  • 2014-  Vice President of “Lotos” a non profit organization for the education awareness and support for breast reconstruction
  • 2014  Vice President Hellenic Society for Fertility Preservation
  • 2014  W40 Women in Oncology-Greek section

Publications

  • CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects.  Apostolou P, Dellatola V, Papadimitriou C, Kalfakakou D, Fountzilas E, Faliakou E, Fountzilas G, Romanidou O, Konstantopoulou I, Fostira F.Apostolou P, et al. Cancers (Basel). 2021 Apr 27;13(9):2106. doi: 10.3390/cancers13092106.Cancers (Basel). 2021. PMID: 33925588

  • One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene.  Fostira F, Kostantopoulou I, Apostolou P, Papamentzelopoulou MS, Papadimitriou C, Faliakou E, Christodoulou C, Boukovinas I, Razis E, Tryfonopoulos D, Barbounis V, Vagena A, Vlachos IS, Kalfakakou D, Fountzilas G, Yannoukakos D.Fostira F, et al.  J Med Genet. 2020 Jan;57(1):53-61. doi: 10.1136/jmedgenet-2019-106189. Epub 2019 Jul 12.J Med Genet. 2020. PMID: 31300551 Free PMC article.

  • Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients. Apostolou P, Fostira F, Mollaki V, Delimitsou A, Vlassi M, Pentheroudakis G, Faliakou E, Kollia P, Fountzilas G, Yannoukakos D, Konstantopoulou I.Apostolou P, et al.  J Hum Genet. 2018 Jul;63(8):877-886. doi: 10.1038/s10038-018-0466-3. Epub 2018 May 22.J Hum Genet. 2018. PMID: 29785007

  • Long-term quality-of-life assessment following one-stage immediate breast reconstruction using biodimensional expander implants: the patient’s perspective. Gui GPH, Kadayaprath G, Tan SM, Faliakou EC, Choy C, Ward A, A’Hern R.Gui GPH, et al. Plast Reconstr Surg. 2008 Jan;121(1):17-24. doi: 10.1097/01.prs.0000293875.33012.84.Plast Reconstr Surg. 2008. PMID: 18176201

  • Evaluation of outcome after immediate breast reconstruction: prospective comparison of four methods.  Gui GP, Kadayaprath G, Tan SM, Faliakou EC, Choy C, A’Hern R, Ward A.Gui GP, et al.  Plast Reconstr Surg. 2005 Jun;115(7):1916-26. doi: 10.1097/01.prs.0000165081.54107.b9.Plast Reconstr Surg. 2005. PMID: 15923837

  • Immediate breast reconstruction using biodimensional anatomical permanent expander implants: a prospective analysis of outcome and patient satisfaction. Gui GP, Tan SM, Faliakou EC, Choy C, A’Hern R, Ward A.Gui GP, et al.  Plast Reconstr Surg. 2003 Jan;111(1):125-38; discussion 139-40. doi: 10.1097/01.PRS.0000037752.95854.41.Plast Reconstr Surg. 2003. PMID: 12496573

  • Surgical technique: submuscular placement of breast implant ports with delayed expansion following ultrasound localization.  Sarker SK, Faliakou EC, Gui GP.Sarker SK, et al.  Eur J Surg Oncol. 2001 Mar;27(2):212-3. doi: 10.1053/ejso.2000.1034.Eur J Surg Oncol. 2001. PMID: 11289762

  • Isolated sarcoidosis of the breast. Harris KP, Faliakou EC, Exon DJ, Nasiri N, Gui GP.Harris KP, et al. J R Soc Med. 2000 Apr;93(4):196-7. doi: 10.1177/014107680009300413. J R Soc Med. 2000. PMID: 10844889

  • Treatment and outcome of intracystic papillary carcinoma of the breast. Harris KP, Faliakou EC, Exon DJ, Nasiri N, Sacks NP, Gui GP.Harris KP, et al. Br J Surg. 1999 Oct;86(10):1274. doi: 10.1046/j.1365-2168.1999.01254.x.Br J Surg. 1999. PMID: 10540131

  • Selective alpha IIb beta 3 receptor blockage with peptide TP9201 prevents platelet uptake on Dacron vascular grafts without significant effect on bleeding time. Mazur C, Tschopp JF, Faliakou EC, Gould KE, Diehl JT, Pierschbacher MD, Connolly RJ.Mazur C, et al. J Lab Clin Med. 1994 Oct;124(4):589-99.J Lab Clin Med. 1994. PMID: 7523555

  • Comparison of descending phlebography with quantitative photoplethysmography, air plethysmography, and duplex quantitative valve closure time in assessing deep venous reflux. Welch HJ, Faliakou EC, McLaughlin RL, Umphrey SE, Belkin M, O’Donnell TF Jr.Welch HJ, et al. J Vasc Surg. 1992 Dec;16(6):913-9; discussion 919-20.J Vasc Surg. 1992. PMID: 1460718

  • A case of Buerger’s disease with pathology confirmation. Balas P, Faliakou E, Papalambros E.Balas P, et al. Int Angiol. 1991 Oct-Dec;10(4):247-9. Int Angiol. 1991. PMID: 1797935